Is there evidence for the use of Buspirone in controlling breathing-related anxiety in COPD and/or malignancy?
Abstract
The current evidence does not consistently support the use of buspirone for controlling breathing-related anxiety in COPD or malignancy, though some studies suggest potential benefits in COPD.
Fields of Study & Subjects
Chronic Obstructive Pulmonary Disease (COPD) Research
Anxiety
Depression
Psychometrics
Treatment
Cognitive Processes
Asthma and respiratory diseases
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 28 January 2026